Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.
CLH offers the FilmArray Respiratory Panel from BioFire Diagnostics for the detection of 17 respiratory viruses and 3 bacteria from a single specimen. This panel does NOT test for the SARS-CoV-2 virus.
The Centers for Disease Control and Prevention (CDC) and the DOH are closely monitoring the 2019 Novel Coronavirus (2019-nCoV).
Biotin administration (especially in high doses) may impact common, immunoassay-based, laboratory tests.
CLH/PPPL will be performing Human Papillomavirus (HPV) testing locally on Oahu using the Aptima nucleic acid amplification assay.
Clinical Labs of Hawaii is pleased to offer the Rapid Alere Determine™ HIV-1/2 Ag/Ab Combo qualitative immunoassay for the simultaneous detection of HIV-1 p24 antigen and antibodies to HIV-1 and HIV2.
Test codes for CT-GC testing by Transcription Mediated Amplification (TMA) have been updated.
Clinical Labs of Hawaii is please to announce the introduction of the QuantiFERON-TB Gold Plus (QFT-Plus) assay, which offers optimized analyses with tuberculosis (TB)-specific antigens that elict both CD4+ and CD8+ T-cell responses.
Effective January 30, 2019 Clinical Labs of Hawaii will offer in-house testing for N-terminal pro B-type Natriuretic Peptide (NT-proBNP) as a replacement for current BNP testing.
Effective January 30, 2019, Clinical Labs will offer in-house testing for High Sensitivity Cardiac Troponin T (cTnT GEN 5) as a replacement for current Troponin I testing.
Effective January 30, 2019, Clinical Labs of Hawaii will be implementing the Roche Diagnostic Cobas® System of immunoassay analyzers. Please read bulletin for important reference range updates.
Effective January 14th, 2019, Clinical Labs of Hawaii will be offering the FibroACT test for the assessment of liver fibrosis through Sonic Reference Laboratory (SRL).
FibroACT – Non-invasive serum test to assess liver fibrosis and inflammation due to viral hepatitis
Effective January 7, 2019, Clinical Labs of Hawaii will begin reporting estimated glomerular filtration rate (eGFR) using the improved Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) equation.